124 related articles for article (PubMed ID: 1445777)
1. Pros and cons of fluoxetine for the depressed cancer patient.
Shuster JL; Stern TA; Greenberg DB
Oncology (Williston Park); 1992 Nov; 6(11):45-50, 55; discussion 55-6. PubMed ID: 1445777
[TBL] [Abstract][Full Text] [Related]
2. An overview of fluoxetine, a new serotonin-specific antidepressant.
Boyer WF; Feighner JP
Mt Sinai J Med; 1989 Mar; 56(2):136-40. PubMed ID: 2664482
[TBL] [Abstract][Full Text] [Related]
3. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial.
Akhondzadeh Basti A; Moshiri E; Noorbala AA; Jamshidi AH; Abbasi SH; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):439-42. PubMed ID: 17174460
[TBL] [Abstract][Full Text] [Related]
4. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine versus placebo in advanced cancer outpatients.
Alliot C
J Clin Oncol; 2004 Jan; 22(1):204-5; author reply 206-8. PubMed ID: 14701790
[No Abstract] [Full Text] [Related]
6. Treatment of depression. New pharmacologic approaches.
Calabrese JR; Markovitz PJ
Prim Care; 1991 Jun; 18(2):421-33. PubMed ID: 1876622
[TBL] [Abstract][Full Text] [Related]
7. [Antidepressants consumption in the global population in France].
Olié JP; Elomari F; Spadone C; Lépine JP
Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
[TBL] [Abstract][Full Text] [Related]
8. Practical psychopharmacologic considerations in depression.
Brasfield KH
Nurs Clin North Am; 1991 Sep; 26(3):651-63. PubMed ID: 1891399
[TBL] [Abstract][Full Text] [Related]
9. [A test for using meta-analysis to evaluate antidepressive effects of fluoxetine].
Jarema M
Psychiatr Pol; 1996; 30(4):569-81. PubMed ID: 8975258
[TBL] [Abstract][Full Text] [Related]
10. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy.
Navari RM; Brenner MC; Wilson MN
Breast Cancer Res Treat; 2008 Nov; 112(1):197-201. PubMed ID: 18064563
[TBL] [Abstract][Full Text] [Related]
11. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.
Holland JC; Romano SJ; Heiligenstein JH; Tepner RG; Wilson MG
Psychooncology; 1998; 7(4):291-300. PubMed ID: 9741068
[TBL] [Abstract][Full Text] [Related]
12. Suicidality and fluoxetine: is there a relationship?
Fava M; Rosenbaum JF
J Clin Psychiatry; 1991 Mar; 52(3):108-11. PubMed ID: 2005073
[TBL] [Abstract][Full Text] [Related]
13. Gender based response to fluoxetine hydrochloride medication in endogenous depression.
Bano S; Akhter S; Afridi MI
J Coll Physicians Surg Pak; 2004 Mar; 14(3):161-5. PubMed ID: 15228850
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
Zajecka JM; Jeffries H; Fawcett J
J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine in family practice patients.
Taylor AT; Wagner PJ; Pritchard DC; Tollison JW
J Fam Pract; 1994 Jul; 39(1):45-9. PubMed ID: 8027732
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine.
Gram L
N Engl J Med; 1994 Nov; 331(20):1354-61. PubMed ID: 7935707
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group.
Fisch MJ; Loehrer PJ; Kristeller J; Passik S; Jung SH; Shen J; Arquette MA; Brames MJ; Einhorn LH;
J Clin Oncol; 2003 May; 21(10):1937-43. PubMed ID: 12743146
[TBL] [Abstract][Full Text] [Related]
18. A multicentre open trial of fluoxetine in depressed out-patients in Belgium.
Brasseur R
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():107-11. PubMed ID: 2644335
[TBL] [Abstract][Full Text] [Related]
19. No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline.
Roberts RL; Mulder RT; Joyce PR; Luty SE; Kennedy MA
Hum Psychopharmacol; 2004 Jan; 19(1):17-23. PubMed ID: 14716707
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
Tollefson GD; Holman SL; Sayler ME; Potvin JH
J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
